Asthma Clinical Trials Recruiting in the US
125 studies for Asthma are recruiting at 565 US sites, according to ClinicalTrials.gov data processed .
Asthma is a long-term lung condition in which the airways become inflamed and narrowed, which can cause wheezing, coughing and shortness of breath.
Recruiting now
Top Asthma studies by number of US sites
Showing 30 studies, most US recruiting sites first.
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
NCT06307665
- Phase 3
- Ages 12 to 17 years
- Sex: All
- Recruiting sites
- 82 US recruiting sites
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
NCT07276724
- Phase 3
- Ages 12 to 80 years
- Sex: All
- Recruiting sites
- 36 US recruiting sites
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 35 US recruiting sites
- A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
NCT07323654
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 34 US recruiting sites
- Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
NCT06750289
- Phase 3
- Ages 12 to 75 years
- Sex: All
- Recruiting sites
- 23 US recruiting sites
- Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
NCT06932263
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 22 US recruiting sites
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
NCT07359846
- Phase 3
- Ages 12 to 80 years
- Sex: All
- Recruiting sites
- 21 US recruiting sites
- A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
NCT05757102
- Phase 3
- Ages 12 to 17 years
- Sex: All
- Recruiting sites
- 20 US recruiting sites
- A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
NCT06023589
- Phase 3
- Ages 5 to 11 years
- Sex: All
- Recruiting sites
- 20 US recruiting sites
- ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
NCT07301255
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 20 US recruiting sites
- A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
NCT07219173
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 16 US recruiting sites
- A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
NCT07456033
- Phase 3
- Ages 12 years and older
- Sex: All
- Recruiting sites
- 16 US recruiting sites
- Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
NCT07228026
- Observational
- Ages 5 to 100 years
- Sex: All
- Recruiting sites
- 13 US recruiting sites
- A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
NCT07525375
- Phase 2
- Ages 4 to 11 years
- Sex: All
- Recruiting sites
- 12 US recruiting sites
- A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
NCT07645248
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 12 US recruiting sites
- A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
NCT07532265
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 9 US recruiting sites
- Protocol CAUSE-03 / CHEETAH
NCT06136091
- Observational
- Ages 6 to 17 years
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 8 US recruiting sites
- Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
NCT06979323
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 8 US recruiting sites
- Individualizing Treatment for Asthma in Primary Care (Full Study)
NCT07052942
- Phase 4
- Ages 13 to 75 years
- Sex: All
- Recruiting sites
- 8 US recruiting sites
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
NCT07772921
- Phase 3
- Ages 12 to 80 years
- Sex: All
- Recruiting sites
- 7 US recruiting sites
- Registry of Asthma Characterization and Recruitment 3 (RACR3)
NCT05272241
- Observational
- Ages Any age
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 5 US recruiting sites
- CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
NCT07241117
- Phase 4
- Ages 12 years and older
- Sex: All
- Recruiting sites
- 5 US recruiting sites
- A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
NCT07556159
- Observational
- Ages 6 years and older
- Sex: All
- Recruiting sites
- 5 US recruiting sites
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
NCT04278404
- Observational
- Ages 0 to 20 years
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 4 US recruiting sites
- A Study of CDX-622 in Participants With Mild to Moderate Asthma
NCT07330778
- Phase 1
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 4 US recruiting sites
- Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
NCT06385236
- Phase 4
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 3 US recruiting sites
- A Study of Depemokimab in Participants of 6 to 11 Years of Age
NCT07671001
- Phase 3
- Ages 6 to 11 years
- Sex: All
- Recruiting sites
- 3 US recruiting sites
- A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
NCT07677059
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 3 US recruiting sites
- Personalized Environment and Genes Study
NCT00341237
- Observational
- Ages 18 to 120 years
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 2 US recruiting sites
- Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
NCT03263130
- Observational
- Ages 30 years and older
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 2 US recruiting sites
By city
Asthma clinical trials by city
FAQ
Common questions
What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Asthma clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.